Loading…
TuHURA Biosciences, Inc. is projected to rise to $3.87 by 2027, a +63% move from its current price of $2.38. HURA is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.26 | $2.38 | $2.51 | +0.02% |
| May 30 | $2.21 | $2.38 | $2.57 | +0.05% |
| May 31 | $2.17 | $2.38 | $2.61 | +0.07% |
| Jun 1 | $2.14 | $2.38 | $2.65 | +0.10% |
| Jun 2 | $2.11 | $2.38 | $2.69 | +0.12% |
| Jun 3 | $2.09 | $2.38 | $2.72 | +0.15% |
| Jun 4 | $2.07 | $2.38 | $2.75 | +0.17% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.07 | $2.38 | $2.75 | +0.17% |
| Week 2 | $1.95 | $2.39 | $2.92 | +0.34% |
| Week 3 | $1.87 | $2.39 | $3.06 | +0.51% |
| Week 4 | $1.80 | $2.40 | $3.18 | +0.69% |
| Week 5 | $1.75 | $2.40 | $3.30 | +0.86% |
| Week 6 | $1.70 | $2.40 | $3.40 | +1.03% |
| Week 7 | $1.66 | $2.41 | $3.50 | +1.21% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
TuHURA Biosciences, Inc. is a clinical stage immuno-oncology company that develops novel technologies for the treatment of cancer immunotherapies. Its lead product candidate is IFx2.0, an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
The company is also pursuing Delta receptor technology to develop tumor microenvironment modulators in the form of first-in-class bi-functional and bi-specific antibody-drug conjugates targeting Myeloid Derived Suppressor Cells. It is developing Immune Fx; IFx-3.0, an mRNA innate immune agonist candidate for intravenous or autologous whole cell administration for blood-related cancers. Formerly Morphogenesis, Inc., the company changed its name to TuHURA Biosciences, Inc.
in December 2023. Founded in 1995 and based in Tampa, Florida, TuHURA Biosciences, Inc. operates as a subsidiary of CohBar, Inc.
TuHURA Biosciences, Inc. trades under the symbol HURA. It currently trades at $2.50 and has a market capitalization of $159.21M, ranking 3987. The stock’s current price sits at $2.50 with a 30-day price range implied by nearby technicals.
Forecasts indicate significant potential upside in the long term, with the average price progressing from $2.50 in 2026 to $58.93 by 2050 and a max of $135.54 in 2050. The annualized ROIs rise across the horizon, reaching 2257.3% by 2050.
A major floor 81.5% below — a decisive break under it would weaken the trend.
The nearest floor, 11.8% below — buyers have tended to step in here.
The nearest ceiling, 29.0% above — a clean break opens room to run.
A major ceiling 46.5% above — clearing it would confirm fresh momentum.
Key HURA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of HURA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.41 | Sell | $2.42 | Sell |
| MA 10 | $2.44 | Sell | $2.42 | Sell |
| MA 20 | $2.38 | Sell | $2.40 | Sell |
| MA 50 | $2.26 | Buy | $2.22 | Buy |
| MA 100 | $1.67 | Buy | $2.01 | Buy |
| MA 200 | $1.93 | Buy | $2.43 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.36 | Neutral |
| Stoch RSI (14) | 12.77 | Buy |
| CCI (20) | -2.56 | Neutral |
| Williams %R (14) | -70.83 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.49 | Neutral |
| Stochastic %K (14) | 29.17 | Neutral |
| TRIX (15) | 0.34 | Buy |
| Awesome (5,34) | -0.06 | Sell |
| Ultimate (7,14,28) | 49.49 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 2.42 | Sell |
| ADX (14) | 10.23 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture is bullish overall, with RSI14 at 50, suggesting neutral momentum around the midline. The stock is trading above both the 50-day and 200-day moving averages, with SMA50 at $2.24 and SMA200 at $1.93, indicating a constructive near-term trend. Support is at $2.10 and resistance at $3.15, framing a near-term range that spans roughly from $1.72 to $3.63 over the past 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.44 | $2.38 | $3.22 | 0% | Neutral | |
| $2.79 | $3.87 | $5.82 | +63% | Bullish | |
| $3.66 | $5.40 | $8.64 | +127% | Bullish | |
| $3.69 | $5.73 | $9.61 | +141% | Bullish | |
| $4.55 | $7.41 | $12.91 | +211% | Bullish | |
| $4.39 | $7.47 | $13.47 | +214% | Bullish | |
| $3.97 | $7.04 | $13.09 | +196% | Bullish | |
| $5.01 | $9.25 | $17.66 | +289% | Bullish | |
| $6.31 | $12.11 | $23.71 | +409% | Bullish | |
| $7.81 | $15.57 | $31.19 | +554% | Bullish | |
| $9.50 | $21.12 | $46.45 | +787% | Bullish | |
| $20.64 | $45.86 | $105.48 | +18.3x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.44 | $2.38 | $2.83 | +0.00% |
| June 2026 | $2.07 | $2.48 | $3.08 | +4.11% |
| July 2026 | $2.00 | $2.43 | $3.10 | -1.79% |
| August 2026 | $1.78 | $2.20 | $2.86 | -9.41% |
| September 2026 | $1.76 | $2.20 | $2.91 | -0.04% |
| October 2026 | $1.88 | $2.38 | $3.18 | +7.84% |
| November 2026 | $1.85 | $2.36 | $3.20 | -0.66% |
| December 2026 | $1.83 | $2.35 | $3.22 | -0.36% |
Click any year to see its month-by-month HURA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The HURA price prediction for 2026 points to an average of $2.38 (low $0.44, high $3.22) — a potential gain of 0% on today's $2.38. A consolidation phase looks the most probable path here.
In 2027, HURA is projected to trade between $2.79 and $5.82, averaging $3.87 — a potential gain of +63% from today's $2.38. That is up +63% on the projected 2026 average. Momentum favours further upside here.
TuHURA Biosciences, Inc.'s 2028 outlook centres on $5.40, within a $3.66 to $8.64 range. That is up +40% on the projected 2027 average. That marks a +127% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, HURA could reach as high as $9.61, with a base case around $5.73 and support toward $3.69 — roughly +141% from $2.38. Momentum favours further upside here.
Expect HURA to range from $4.55 to $12.91 through 2030. The $7.41 average target implies a +211% move from current prices. That is up +29% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The HURA price prediction for 2031 points to an average of $7.47 (low $4.39, high $13.47) — a potential gain of +214% on today's $2.38. Momentum favours further upside here.
In 2032, HURA is projected to trade between $3.97 and $13.09, averaging $7.04 — a potential gain of +196% from today's $2.38. That is -6% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
TuHURA Biosciences, Inc.'s 2033 outlook centres on $9.25, within a $5.01 to $17.66 range. That is up +31% on the projected 2032 average. That marks a +289% change versus current levels. Momentum favours further upside here.
By 2034, HURA could reach as high as $23.71, with a base case around $12.11 and support toward $6.31 — roughly +409% from $2.38. Buyers look set to stay in control over this stretch.
Expect HURA to range from $7.81 to $31.19 through 2035. The $15.57 average target implies a +554% move from current prices. That is up +29% on the projected 2034 average. Momentum favours further upside here.
The HURA price prediction for 2040 points to an average of $21.12 (low $9.50, high $46.45) — a potential gain of +787% on today's $2.38. Buyers look set to stay in control over this stretch.
In 2050, HURA is projected to trade between $20.64 and $105.48, averaging $45.86 — a potential gain of +18.3x from today's $2.38. That is up +117% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in HURA today (≈ 420.168067 HURA) could be worth
$19,268.58
+$18,268.58 (+1827%) by 2050 · US Dollar
Based on the average projected HURA price of $45.86 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in HURAwould be worth at today's price.
$1,000 invested in HURA on May 27, 2025 (≈ 340.136048 HURA) would be worth
$809.52
-$190.48 (-19.0%) today · 0.81× · US Dollar
Based on a HURA entry price of $2.94 vs. today's $2.38.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.39 | $995.82 | -0.4% |
| 1 month ago | $2.22 | $1,072.07 | +7.2% |
| 3 months ago | $1.62 | $1,469.14 | +46.9% |
| 6 months ago | $2 | $1,190 | +19.0% |
| 1 year ago | $2.94 | $809.52 | -19.0% |
| All time (5.0y) ago | $2,835 | $0.84 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our HURA forecast.
Our base-case forecast reaches $4.80 around 2028.
Implied market cap at $4.80: $305.68M
The multi-year forecast shows a clear growth path in average price from $2.50 in 2026 to $58.93 in 2050, with a wide max of $135.54 in 2050. Notable mid-term milestones include 2027 at an average of $4.39 (ROI 75.5%) and 2030 at an average of $8.60 (ROI 243.9%), followed by 2040 at an average of $26.59 (ROI 963.6%). The long-range outlook culminates in 2050 with an average of $58.93 and a max of $135.54 (ROI 2257.3%).
These figures imply substantial upside but remain estimates, not guarantees, and depend on multiple factors, including clinical progress and market conditions.
Tap a question to reveal the answer.
The forecast shows an average price of $8.60 in 2030, with a min of $5.28 and a max of $15.00; ROI is 243.9% and sentiment is BULLISH.
The forecast projects meaningful upside over the long term, with rising average prices from 2027 onward and positive ROIs (e.g., 75.5% in 2027 and up to 2257.3% by 2050). In 2026 the sentiment is Neutral and the average price is $2.50, reflecting a cautious near-term view.
Yes. The max forecast by 2050 is $135.54, which surpasses $100.
Min $11.97, Avg $26.59, Max $58.50; ROI 963.6%, sentiment BULLISH.
TuHURA Biosciences, Inc. Community Discussion
0Share your TuHURA Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.